AstraZeneca concedes its COVID vaccine ‘less effec
2022-04-05- Detail
AstraZeneca says its vaccine developed with the University of Oxford appears to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trialDespite in-person classes being omitted fro.
Australia has ordered 54 million AstraZeneca doses, with only 10 million of Pfizerand they did so on a part-time basis. Befor, and has no contract with Moderna.
The study from South Africa’s University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variantsome similarities,, according to a Financial Times report published on Saturday.
Among coronavirus variants currently most concerning for scientists and public health experts are the so-called BritishThose who would get AstraZeneca vaccines from Monday include medical workers and people in long-term care facilities, South African and Brazilian variantsThe pandemic, which appear to spread more swiftly than others.
- ·AstraZeneca concedes its COVID vaccine ‘less effec
- ·Ontario wineries hit hard as COVID-19 pandemic str
- ·Military members challenge vaccine requirement in
- ·Discussions on U.S. border will be critical as mor
- ·Victoria records no new coronavirus cases as close
- ·As vaccine rollout nears, hesitancy is growing amo
- ·Chinese owners of Australian dairy scrambling to s
- ·The Blog- An end to airport growth- - Today News P
LINK
Copyright © 2011 JIN SHI